• Something wrong with this record ?

Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice

H. Geng, W. Zou, M. Zhang, L. Xu, F. Liu, X. Li, L. Wang, Y. Xu,

. 2020 ; 65 (2) : 339-351. [pub] 20190630

Language English Country United States

Document type Evaluation Study, Journal Article

Grant support
No. 2018YFD0500600 National Key R&D Program of China
Grant No. 201405003 National Public Science and Technology Research Funds Projects of Ocean

Mastitis in dairy cows is generally considered to be the most expensive disease for dairy farmers worldwide. The overuse of antibiotics is a major problem in the treatment of bovine mastitis, and bacteriophage therapy is expected to provide an alternative treatment. The primary aim of this study was to evaluate the efficacy of a phage cocktail against mastitis in a mouse model. First, a Staphylococcus aureus strain was isolated from milk samples taken from mastitis cows from dairy farms in Xinjiang, China, and it was designated as Sau-XJ-21. Next, two phages (designated as vBSM-A1 and vBSP-A2) with strong lytic activity against Sau-XJ-21 were isolated from mixed sewage samples collected from three cattle farms in Xinjiang. Phages vBSM-A1 and vBSP-A2 were identified as members of the Myoviridae and Podoviridae families, respectively. The two phages exhibited a wide range of hosts, especially phage vBSM-A1. To evaluate the effectiveness of the two phages in the treatment against mastitis, female lactating mice were used 10-14 days after giving births. The mice were divided into six groups; one group was kept as healthy control, while the remaining five groups were inoculated with the isolated S. aureus strain to induce mastitis. Four hours after bacterial inoculation, mice in these groups were injected with 25 μL phosphate buffer saline (negative control), ceftiofur sodium (positive control), or phage, either individually or as a cocktail. The mice were sacrificed 20 h later, and the mammary glands were removed and subjected to further analysis, including the quantitation of colony-forming units (CFU), plaque-forming units (PFU), and gross macroscopic as well as histopathology observation. Mice with induced mastitis exhibited significantly improved mastitic pathology and decreased bacterial counts after they had been given phage treatments, with the phage cocktail being more superior than either phage alone. Furthermore, the cocktail treatment also maintained the highest intramammary phage titer without spreading systemically. The effectiveness of the phage cocktail was comparable to that produced by ceftiofur sodium. According to the data obtained for the mouse model of mastitis, phage therapy could be considered as an innovative alternative to antibiotics for the treatment of bovine mastitis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024268
003      
CZ-PrNML
005      
20201208102230.0
007      
ta
008      
201208s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-019-00729-9 $2 doi
035    __
$a (PubMed)31256341
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Geng, Huijun $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
245    10
$a Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice / $c H. Geng, W. Zou, M. Zhang, L. Xu, F. Liu, X. Li, L. Wang, Y. Xu,
520    9_
$a Mastitis in dairy cows is generally considered to be the most expensive disease for dairy farmers worldwide. The overuse of antibiotics is a major problem in the treatment of bovine mastitis, and bacteriophage therapy is expected to provide an alternative treatment. The primary aim of this study was to evaluate the efficacy of a phage cocktail against mastitis in a mouse model. First, a Staphylococcus aureus strain was isolated from milk samples taken from mastitis cows from dairy farms in Xinjiang, China, and it was designated as Sau-XJ-21. Next, two phages (designated as vBSM-A1 and vBSP-A2) with strong lytic activity against Sau-XJ-21 were isolated from mixed sewage samples collected from three cattle farms in Xinjiang. Phages vBSM-A1 and vBSP-A2 were identified as members of the Myoviridae and Podoviridae families, respectively. The two phages exhibited a wide range of hosts, especially phage vBSM-A1. To evaluate the effectiveness of the two phages in the treatment against mastitis, female lactating mice were used 10-14 days after giving births. The mice were divided into six groups; one group was kept as healthy control, while the remaining five groups were inoculated with the isolated S. aureus strain to induce mastitis. Four hours after bacterial inoculation, mice in these groups were injected with 25 μL phosphate buffer saline (negative control), ceftiofur sodium (positive control), or phage, either individually or as a cocktail. The mice were sacrificed 20 h later, and the mammary glands were removed and subjected to further analysis, including the quantitation of colony-forming units (CFU), plaque-forming units (PFU), and gross macroscopic as well as histopathology observation. Mice with induced mastitis exhibited significantly improved mastitic pathology and decreased bacterial counts after they had been given phage treatments, with the phage cocktail being more superior than either phage alone. Furthermore, the cocktail treatment also maintained the highest intramammary phage titer without spreading systemically. The effectiveness of the phage cocktail was comparable to that produced by ceftiofur sodium. According to the data obtained for the mouse model of mastitis, phage therapy could be considered as an innovative alternative to antibiotics for the treatment of bovine mastitis.
650    _2
$a zvířata $7 D000818
650    _2
$a bakteriofágy $x fyziologie $7 D001435
650    _2
$a skot $7 D002417
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mastitida skotu $x mikrobiologie $x terapie $7 D008414
650    _2
$a myši $7 D051379
650    _2
$a mléko $x mikrobiologie $7 D008892
650    _2
$a Myoviridae $x fyziologie $7 D017900
650    _2
$a fágová terapie $x metody $x veterinární $7 D000071059
650    _2
$a Podoviridae $x fyziologie $7 D017902
650    _2
$a stafylokokové infekce $x mikrobiologie $x veterinární $7 D013203
650    _2
$a Staphylococcus aureus $x fyziologie $x virologie $7 D013211
651    _2
$a Čína $7 D002681
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zou, Wei $u School of Life Science and Biotechnology, Liaoning Normal University, Dalian, 116029, People's Republic of China.
700    1_
$a Zhang, Meixia $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
700    1_
$a Xu, Le $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
700    1_
$a Liu, Fanming $u School of Life Science and Biotechnology, Liaoning Normal University, Dalian, 116029, People's Republic of China.
700    1_
$a Li, Xiaoyu $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
700    1_
$a Wang, Lili $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
700    1_
$a Xu, Yongping $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China. ghj_abtnl@sina.com. Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116600, People's Republic of China. ghj_abtnl@sina.com.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 65, č. 2 (2020), s. 339-351
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31256341 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20201208 $b ABA008
991    __
$a 20201208102226 $b ABA008
999    __
$a ok $b bmc $g 1593223 $s 1114949
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 65 $c 2 $d 339-351 $e 20190630 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a No. 2018YFD0500600 $p National Key R&D Program of China
GRA    __
$a Grant No. 201405003 $p National Public Science and Technology Research Funds Projects of Ocean
LZP    __
$a Pubmed-20201208

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...